9-136831779-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_024718.5(RABL6):c.517G>A(p.Val173Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00007 in 1,613,386 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_024718.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RABL6 | NM_024718.5 | c.517G>A | p.Val173Met | missense_variant | 6/15 | ENST00000311502.12 | NP_078994.3 | |
RABL6 | NM_001173988.2 | c.517G>A | p.Val173Met | missense_variant | 6/15 | NP_001167459.1 | ||
RABL6 | NM_001173989.4 | c.517G>A | p.Val173Met | missense_variant | 6/8 | NP_001167460.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RABL6 | ENST00000311502.12 | c.517G>A | p.Val173Met | missense_variant | 6/15 | 1 | NM_024718.5 | ENSP00000311134.7 | ||
RABL6 | ENST00000357466.6 | c.517G>A | p.Val173Met | missense_variant | 6/10 | 1 | ENSP00000350056.2 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000804 AC: 20AN: 248700Hom.: 0 AF XY: 0.0000814 AC XY: 11AN XY: 135124
GnomAD4 exome AF: 0.0000671 AC: 98AN: 1461208Hom.: 0 Cov.: 29 AF XY: 0.0000633 AC XY: 46AN XY: 726920
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 08, 2024 | The c.517G>A (p.V173M) alteration is located in exon 6 (coding exon 6) of the RABL6 gene. This alteration results from a G to A substitution at nucleotide position 517, causing the valine (V) at amino acid position 173 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at